Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 28 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 8809310

    Use of rasagiline for the treatment of multiple system atrophy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  2. US 8802854

    Crystalline forms of Prasugrel salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  3. US 8790641

    Production of high mannose proteins in plant culture and therapeutic uses thereof

    Protalix Ltd. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted
  4. US 8759314

    Methods for treating multiple sclerosis using antisense oligonucleotides

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  5. US 8759302

    Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  6. US 8741620

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  7. US 8742079

    Saccharide-containing protein conjugates and uses thereof

    Protalix Ltd. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  8. US 8742129

    Crystalline forms of febuxostat

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  9. US 8729028

    Noggin-derived peptide and use thereof

    CAREGEN CO., LTD. · Granted May 20, 2014 · Expires May 15, 2034

    granted
  10. US 8722722

    Raltegravir salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  11. US 8722863

    Solid state forms of fidaxomycin and processes for preparation thereof

    Teva Pharmaceutical Works Ltd. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  12. US 8709433

    Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted
  13. US 8691872

    Dispersions of rasagiline citrate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  14. US 8691195

    Peptide having activity of transforming growth factor and production method therefor

    CAREGEN CO., LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  15. US 8673322

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  16. US 8663703

    Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  17. US 8663987

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  18. US 8653060

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  19. US 8647670

    Biocompatible rapid-gelating hydrogel and associated preparation method of spray

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  20. US 8647646

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  21. US 8622920

    Breath test device and method

    EXALENZ BIOSCIENCE LTD. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted
  22. US 8614252

    Crystalline solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted
  23. US 8609235

    Porous ceramic material and method of producing the same

    KURARAY CO., LTD. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted
  24. US 8597666

    Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted